Skip to main content
WGS logo

WGS · GeneDx Holdings Corp. · Metrics

Track WGS — free
$49.24 -2.72 (-5.23%) At close · Nov 19 Play latest call Q3 2026 earnings call transcript
Market Cap
$1.48B
Shares
29.97M
Volume · Nov 19 920.82K Avg daily vol (3M) 862.41K

WGS metrics

86 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$49.24
Market cap
$1.48B

Price action

23 metrics
Price change (1W)
-5.1%
Price change (30D)
-28.6%
Price change (3M)
-40.4%
Price change (6M)
+4.0%
Price change (YTD)
-62.1%
Price change (1Y)
-63.2%
Trailing year
Price change (5Y)
—
52-week high
$167.52
52-week low
$34.51
Change from 52-week high
-70.6%
Change from 52-week low
+42.7%
Annualized volatility
91.5%
Annualized volatility (3M)
87.5%
Implied volatility (30D)
81.2%
IV rank (1Y)
23.2
IV percentile (1Y)
53.8
Beta
1.7
RSI (14D)
36.5
Price vs SMA 50
-30.6%
Price vs SMA 200
-28.7%
Avg volume (3M)
862,404
Relative volume
1.1
Average dollar volume
$60.98M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
29.97M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.2×
reciprocal yield 31.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
3.2×
reciprocal yield 31.2%
P / book
6.0
reciprocal yield 16.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
5.3×
reciprocal yield 19.0%
EV / revenue historical average (5Y)
3.7×
reciprocal yield 27.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-09

Profitability

9 metrics
Gross margin
68.7%
Operating margin
-21.6%
Trailing 12 months
Net margin
-24.1%
Gross profit (TTM)
$316.78M
Operating profit (TTM)
−$99.59M
Net income (TTM)
−$111.05M
Trailing 12 months
Diluted EPS (TTM)
$-3.76
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$15.80
Gross profit per diluted share (TTM)
$10.86
Operating profit per diluted share (TTM)
$-3.41
EBITDA per diluted share (TTM)
$-3.00
Net income per diluted share (TTM)
$-3.80
Operating cash flow per diluted share (TTM)
$-2.55
Free cash flow per diluted share (TTM)
$-2.57
Capital expenditures per diluted share (TTM)
$0.93
R&D per diluted share (TTM)
$2.80
Stock compensation per diluted share (TTM)
$1.15
Book value per share
$10.54

Growth

11 metrics
Revenue growth YoY
+5.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$460.78M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.8%
Year over year · more shares
Revenue CAGR (3Y)
+22.1%
Revenue CAGR (5Y)
+19.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-45.4%
Return on assets
-21.1%
Debt / equity
0.6
Current ratio
4.2
EBITDA (TTM)
−$87.79M
Free cash flow (TTM)
—
Quick ratio
3.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$23.89M
Latest balance sheet
Cash & equivalents
$96.14M
Total assets
$526.48M
Total debt
$146.23M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$75.08M
Capital expenditures (TTM)
$26.14M
R&D (TTM)
$81.37M
SG&A (TTM)
—
Stock compensation (TTM)
$33.37M
R&D / revenue
17.7%
Stock compensation / revenue
7.2%

Ownership (13F)

9 metrics
13F filers
219
13F filer change QoQ
-7
Institutional ownership
112.5%
Conviction holders (share of 13F filers)
2.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+8.8%
Holder tenure
12.4
Price vs estimated holder cost
-4.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
9.2%

Short interest

3 metrics
Short interest
21.9%
Latest settlement · 7.3 days to cover
Days to cover
7.3d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.84M
Insider-sentiment score
20 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1818331 CUSIP 81663L200 13F (30d) 241 filings 211 filers Visit website Investor relations